275 related articles for article (PubMed ID: 19362139)
1. Differential modulation of CNS-specific effector and regulatory T cells during tolerance induction by recombinant invariant chains in vivo.
Lange C; Doster H; Steinbach K; Kalbacher H; Scholl M; Melms A; Bischof F
Brain Behav Immun; 2009 Aug; 23(6):861-7. PubMed ID: 19362139
[TBL] [Abstract][Full Text] [Related]
2. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
[TBL] [Abstract][Full Text] [Related]
3. CD62L(high) Treg cells with superior immunosuppressive properties accumulate within the CNS during remissions of EAE.
Lange C; Scholl M; Melms A; Bischof F
Brain Behav Immun; 2011 Jan; 25(1):120-6. PubMed ID: 20837133
[TBL] [Abstract][Full Text] [Related]
4. Epicutaneously induced TGF-beta-dependent tolerance inhibits experimental autoimmune encephalomyelitis.
Szczepanik M; Tutaj M; Bryniarski K; Dittel BN
J Neuroimmunol; 2005 Jul; 164(1-2):105-14. PubMed ID: 15899524
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
Kosiewicz MM; Alard P; Liang S; Clark SL
Int Immunol; 2004 May; 16(5):697-706. PubMed ID: 15096489
[TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of experimental autoimmune encephalomyelitis with recombinant adeno-associated virus-mediated alpha-melanocyte-stimulating hormone-transduced PLP139-151-specific T cells.
Han D; Tian Y; Zhang M; Zhou Z; Lu J
Gene Ther; 2007 Mar; 14(5):383-95. PubMed ID: 17066098
[TBL] [Abstract][Full Text] [Related]
7. Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis.
Weinberg AD; Wegmann KW; Funatake C; Whitham RH
J Immunol; 1999 Feb; 162(3):1818-26. PubMed ID: 9973447
[TBL] [Abstract][Full Text] [Related]
8. CD62L is required for the priming of encephalitogenic T cells but does not play a major role in the effector phase of experimental autoimmune encephalomyelitis.
Li O; Liu JQ; Zhang H; Zheng P; Liu Y; Bai XF
Scand J Immunol; 2006 Aug; 64(2):117-24. PubMed ID: 16867156
[TBL] [Abstract][Full Text] [Related]
9. Specific treatment of autoimmunity with recombinant invariant chains in which CLIP is replaced by self-epitopes.
Bischof F; Wienhold W; Wirblich C; Malcherek G; Zevering O; Kruisbeek AM; Melms A
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12168-73. PubMed ID: 11593032
[TBL] [Abstract][Full Text] [Related]
10. Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis.
van Zwam M; Huizinga R; Heijmans N; van Meurs M; Wierenga-Wolf AF; Melief MJ; Hintzen RQ; 't Hart BA; Amor S; Boven LA; Laman JD
J Pathol; 2009 Mar; 217(4):543-51. PubMed ID: 19023878
[TBL] [Abstract][Full Text] [Related]
11. CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells.
Meiron M; Zohar Y; Anunu R; Wildbaum G; Karin N
J Exp Med; 2008 Oct; 205(11):2643-55. PubMed ID: 18852294
[TBL] [Abstract][Full Text] [Related]
12. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system.
Prinz M; Schmidt H; Mildner A; Knobeloch KP; Hanisch UK; Raasch J; Merkler D; Detje C; Gutcher I; Mages J; Lang R; Martin R; Gold R; Becher B; Brück W; Kalinke U
Immunity; 2008 May; 28(5):675-86. PubMed ID: 18424188
[TBL] [Abstract][Full Text] [Related]
13. Astrocyte-induced regulatory T cells mitigate CNS autoimmunity.
Trajkovic V; Vuckovic O; Stosic-Grujicic S; Miljkovic D; Popadic D; Markovic M; Bumbasirevic V; Backovic A; Cvetkovic I; Harhaji L; Ramic Z; Mostarica Stojkovic M
Glia; 2004 Aug; 47(2):168-79. PubMed ID: 15185395
[TBL] [Abstract][Full Text] [Related]
14. Role of MHC class II expressing CD4+ T cells in proteolipid protein(91-110)-induced EAE in HLA-DR3 transgenic mice.
Mangalam A; Rodriguez M; David C
Eur J Immunol; 2006 Dec; 36(12):3356-70. PubMed ID: 17125142
[TBL] [Abstract][Full Text] [Related]
15. IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation in vivo.
Gyülvészi G; Haak S; Becher B
Eur J Immunol; 2009 Jul; 39(7):1864-9. PubMed ID: 19544494
[TBL] [Abstract][Full Text] [Related]
16. Cellular mechanisms that maintain neonatally-induced tolerance of class II alloantigens. Evidence that factor-mediated suppression silences cytotoxic T cell activity.
Matriano JA; Socarras S; Streilein JW
J Immunol; 1994 Aug; 153(4):1505-14. PubMed ID: 7913940
[TBL] [Abstract][Full Text] [Related]
17. Defining antigen-dependent stages of T cell migration from the blood to the central nervous system parenchyma.
Archambault AS; Sim J; Gimenez MA; Russell JH
Eur J Immunol; 2005 Apr; 35(4):1076-85. PubMed ID: 15761850
[TBL] [Abstract][Full Text] [Related]
18. Induction of EAE by T cells specific for alpha B-crystallin depends on prior viral infection in the CNS.
Verbeek R; van Dongen H; Wawrousek EF; Amor S; van Noort JM
Int Immunol; 2007 Mar; 19(3):277-85. PubMed ID: 17267417
[TBL] [Abstract][Full Text] [Related]
19. Mannosylated self-peptide inhibits the development of experimental autoimmune encephalomyelitis via expansion of nonencephalitogenic T cells.
Kel JM; Slütter B; Drijfhout JW; Koning F; Nagelkerken L
J Leukoc Biol; 2008 Jul; 84(1):182-90. PubMed ID: 18424662
[TBL] [Abstract][Full Text] [Related]
20. CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells.
Perruche S; Zhang P; Liu Y; Saas P; Bluestone JA; Chen W
Nat Med; 2008 May; 14(5):528-35. PubMed ID: 18438416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]